Sandoz US News

sandoz_us_news.jpg

Sandoz announces agreement with The Medicines Company to launch an authorized generic of ANGIOMAX®

Sandoz announces agreement with The Medicines Company to launch an authorized generic of ANGIOMAX®

Sandoz announces US launch of GlatopaTM, the first generic competitor to Copaxone® 20mg

Holzkirchen, Germany, June 18, 2015 – Sandoz, a Novartis company, today announced the US launch of GlatopaTM, the first generic version of Teva’s Copaxone® (glatiramer acetate injection) 20 mg/ml one-time-daily multiple sclerosis therapy. hydrochloride extended release tablets, a generic version of INTUNIV®, which is currently marketed by Shire Pharmaceuticals.

Sandoz launches generic version of INTUNIV® extended release tablets in the US

Princeton, New Jersey, June 4, 2015 – Sandoz today announced the US market introduction of guanfacine hydrochloride extended release tablets, a generic version of INTUNIV®, which is currently marketed by Shire Pharmaceuticals.

Product Catalog

Use our Product Catalog tool to search our database for information regarding a specific Sandoz product in the US.

 

Sandoz Careers

sandoz_careers.jpg

Our people are our greatest resource. We are always looking for new colleagues to share in our passion and commitment to making the world a healthier place.

Slideshow Background Images